Status:
COMPLETED
A Study of Zolpidem Tartrate Sublingual Tablet in Adult Patients With Insomnia
Lead Sponsor:
Transcept Pharmaceuticals
Conditions:
Insomnia
Eligibility:
All Genders
18-64 years
Phase:
PHASE3
Brief Summary
The purpose of the study is to evaluate sleep onset following administration of zolpidem tartrate sublingual tablet (Intermezzo) versus placebo in adult insomnia patients.
Eligibility Criteria
Inclusion
- Adults with history of sleeplessness
Exclusion
- Allergic to investigational drug
- Any conditions and medications that may interfere with study drug evaluation
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
295 Patients enrolled
Trial Details
Trial ID
NCT00466193
Start Date
May 1 2007
End Date
November 1 2007
Last Update
February 14 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Transcept Investigational Site
Durham, North Carolina, United States, 27710